Abingworth as of March 31, 2014
Portfolio Holdings for Abingworth
Abingworth holds 13 positions in its portfolio as reported in the March 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prosensa Hldgs B V Shs Usd | 19.2 | $35M | 6.2M | 5.61 | |
| Dicerna Pharmaceuticals | 18.4 | $33M | 1.2M | 28.18 | |
| Supernus Pharmaceuticals (SUPN) | 17.7 | $32M | 3.6M | 8.93 | |
| Portola Pharmaceuticals | 17.7 | $32M | 1.2M | 25.90 | |
| Amarin Corporation (AMRN) | 8.1 | $15M | 8.1M | 1.81 | |
| Cempra | 4.5 | $8.2M | 714k | 11.54 | |
| OncoGenex Pharmaceuticals | 3.9 | $7.1M | 604k | 11.74 | |
| Zogenix | 3.7 | $6.6M | 2.3M | 2.84 | |
| Gw Pharmaceuticals Plc ads | 3.4 | $6.1M | 102k | 59.36 | |
| Regulus Therapeutics | 1.6 | $2.9M | 327k | 8.99 | |
| Hyperion Therapeutics | 0.9 | $1.6M | 63k | 25.79 | |
| Anthera Pharmaceuticals | 0.8 | $1.5M | 438k | 3.35 | |
| Zalicus | 0.1 | $96k | 79k | 1.22 |
